METHODS OF ISOLATING CELLS FROM PLACENTAL TISSUE

    公开(公告)号:US20210123015A1

    公开(公告)日:2021-04-29

    申请号:US17031611

    申请日:2020-09-24

    IPC分类号: C12N5/073

    摘要: Methods for isolating a population of cells from tissue are disclosed herein. In particular, the present disclosure provides methods for isolating cytotrophoblasts from placental tissue. The methods include isolating a population of cells with the use of a laboratory apparatus that is coated with a lubricant, such as petroleum jelly. The methods described herein achieve consistent in vitro isolation of purified cells.

    ANTIVIRAL AGENTS FOR TREATMENT OF CORONAVIRUSES

    公开(公告)号:US20220000904A1

    公开(公告)日:2022-01-06

    申请号:US17244272

    申请日:2021-04-29

    摘要: An antiviral agent is provided, having a phosphorodiamidate morpholino oligomer with an antisense sequence to a portion of a genome of a strain of a coronavirus. The coronavirus may be SARS-CoV-2 or another βCoV. The antiviral agent finds many uses, such as in a pharmaceutical composition, a method of treating coronavirus-mediated disease, a method of preventing coronavirus-mediated disease, a method of reducing or preventing the replication of coronavirus in a host cell, a method of controlling the spread of coronavirus in donated tissue, a treated tissue sample, and in the manufacture of a medicament for the treatment or prevention or coronavirus-mediated disease.

    Antiviral agents
    8.
    发明授权

    公开(公告)号:US11174482B2

    公开(公告)日:2021-11-16

    申请号:US16436696

    申请日:2019-06-10

    摘要: An antiviral agent is provided, having a phosphorodiamidate morpholino oligomer with an antisense sequence to a portion of a genome of a strain of Zika virus (ZIKV). The antiviral agent finds many uses, such as in a pharmaceutical composition, a method of treating ZIKV-mediated disease, a method of preventing ZIKV-mediated disease, a method of reducing or preventing the replication of ZIKV in a host cell, a method of controlling the spread of ZIKV in donated tissue, a treated tissue sample, and in the manufacture of a medicament for the treatment or prevention or ZIKV-mediated disease.